Case Presentation: Three male patients were visited in the Dermatology department and received treatment with topical 3% di-clofenac gel because of scalp AK. All patients also had concomitant androgenetic alopecia (AGA). During the follow-up visits, patients presented terminal hair growth on non-...
Topical 3% diclofenac HA gel was well tolerated and did not produce serious adverse cosmetic effects in clinical studies. Common adverse events included skin reddening and irritation, and were generally mild and transient. Diclofenac HA gel is a useful addition to the array of pharmacological ...
Solaraze® (diclofenac sodium) Gel, 3%, contains the active ingredient, diclofenac sodium, in a clear, transparent, colorless to slightly yellow gel base. Diclofenac sodium is a white to slightly yellow crystalline powder. It is freely soluble in methanol, soluble in ethanol, sparingly soluble ...
Diclofenac is also used in the management of actinic keratoses; it is ap- plied twice daily as diclofenac sodium gel 3% for 60 to 90 days but the optimum therapeutic effect may not be seen until 30 days after the end of treatment. Di- clofenac epolamine is also used topically as a ...
In 2016, a case of seborrheic keratosis was successfully treated with diclofenac gel 3%. Diclofenac gel mechanism of action is most likely through induction of apoptosis. This study included 30 patients with multiple seborrheic keratosis. One lesion was treated with topical diclofenac sodium gel 1% ...
Do not use diclofenac topical gel 3% if you have a skin condition such as eczema, a skin infection, burns or wounds.Tell your doctor if you have ever had:heart disease, high blood pressure, high cholesterol, smoking, diabetes; a heart attack, stroke, or blood clot; stomach problems ...
subsequently increases the contact time with the epidermis, thereby increasing uptake of diclofenac by the atypical cells.31Topical diclofenac 3% gel has been used successfully in the treatment ofAKsand is usually well tolerated. In one study, twice-daily application for 60 to 90 days was shown ...
Diclofenac sodium 3% gel as a potential treatment for disseminated superficial actinic porokeratosis We explore the usefulness of a new drying gel containing miconazole nitrate 2% in a unique vehicle for the treatment of chronic intertrigo. Eleven patients... R Varma,W Cantrell,B Elewski - Meeting...
Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety. BACKGROUND: Diclofenac sodium 3% gel (Solaraze) gained US approval for the treatment of actinic keratosis (AK) more than 10 years ago. Since the publicatio... GM Martin...
Topical 3% diclofenac in 2.5% hyaluronic acid (HA) gel (diclofenac HA gel; Solaraze™) is an NSAID approved for the treatment of actinic keratoses (AK). The efficacy of diclofenac HA gel (0.5g applied twice daily to each 5cm × 5cm treatment area) in patients with AK has been ...